Nanosome-Mediated Delivery Of Protein Kinase D Inhibitor Protects Chondrocytes From Interleukin-1β-Induced Stress And Apoptotic Death

References

• Chen D, Shen J, Zhao W, et al. Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res. 2017;5:16044. doi:10.1038/boneres.2016.4428149655
   PubMed Web of Science ®Google Scholar
• Mandl LA. Osteoarthritis year in review 2018: clinical. Osteoarthritis Cartilage. 2019;27(3):359–364. doi:10.1016/j.joca.2018.11.00130453055
   PubMed Web of Science ®Google Scholar
• Mathiessen A, Conaghan PG. Synovitis in osteoarthritis: current understanding with therapeutic implications. Arthritis Res Ther. 2017;19(1):18. doi:10.1186/s13075-017-1229-928148295
   PubMed Web of Science ®Google Scholar
• Wang X, Guo Y, Wang C, Yu H, Yu X, Yu H. MicroRNA-142-3p inhibits chondrocyte apoptosis and inflammation in osteoarthritis by targeting HMGB1. Inflammation. 2016;39(5):1718–1728. doi:10.1007/s10753-016-0406-327447821
   PubMed Web of Science ®Google Scholar
• Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor KappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 2000;43(4):801–811. doi:10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-410765924
   PubMedGoogle Scholar
• Hunter DJ, Felson DT. Osteoarthritis. BMJ. 2006;332(7542):639–642. doi:10.1136/bmj.332.7542.63916543327
   PubMed Web of Science ®Google Scholar
• Kim HA, Blanco FJ. Cell death and apoptosis in osteoarthritic cartilage. Curr Drug Targets. 2007;8(2):333–345. doi:10.2174/13894500777994002517305511
   PubMed Web of Science ®Google Scholar
• Aigner T, Kim HA. Apoptosis and cellular vitality: issues in osteoarthritic cartilage degeneration. Arthritis Rheum. 2002;46(8):1986–1996. doi:10.1002/art.1055412209500
   PubMed Web of Science ®Google Scholar
• Del Carlo M Jr., Loeser RF. Cell death in osteoarthritis. Curr Rheumatol Rep. 2008;10(1):37–42.18457610
   PubMedGoogle Scholar
• Loeser RF. The role of aging in the development of osteoarthritis. Trans Am Clin Climatol Assoc. 2017;128:44–54.28790486
   PubMedGoogle Scholar
• Zemmyo M, Meharra EJ, Kuhn K, Creighton-Achermann L, Lotz M. Accelerated, aging-dependent development of osteoarthritis in alpha1 integrin-deficient mice. Arthritis Rheum. 2003;48(10):2873–2880. doi:10.1002/art.1124614558093
   PubMedGoogle Scholar
• Kunwar A, Kumar M, Singh S. Pathological perspective of chondrocyte apoptosis in osteoarthritis. J Orthopedics Traumatol Rehabil. 2017;9(1):1–5. doi:10.4103/0975-7341.207173
   Google Scholar
• Matsuo M, Nishida K, Yoshida A, Murakami T, Inoue H. Expression of caspase-3 and −9 relevant to cartilage destruction and chondrocyte apoptosis in human osteoarthritic cartilage. Acta Med Okayama. 2001;55(6):333–340. doi:10.18926/AMO/3200011779095
   PubMedGoogle Scholar
• D’Lima DD, Hashimoto S, Chen PC, Lotz MK, Colwell CW Jr. Prevention of chondrocyte apoptosis. J Bone Joint Surg Am. 2001;83-A Suppl 2(Pt 1):25–26. doi:10.2106/00004623-200100021-00006
   PubMedGoogle Scholar
• Nuttall ME, Nadeau DP, Fisher PW, et al. Inhibition of caspase-3-like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro. J Orthop Res. 2000;18(3):356–363. doi:10.1002/jor.110018030610937621
   PubMedGoogle Scholar
• D’Lima D, Hermida J, Hashimoto S, Colwell C, Lotz M. Caspase inhibitors reduce severity of cartilage lesions in experimental osteoarthritis. Arthritis Rheum. 2006;54(6):1814–1821. doi:10.1002/art.2187416736522
   PubMed Web of Science ®Google Scholar
• Sakkas LI, Platsoucas CD. The role of T cells in the pathogenesis of osteoarthritis. Arthritis Rheum. 2007;56(2):409–424. doi:10.1002/art.2236917265476
   PubMedGoogle Scholar
• Koenders MI, Joosten LA, van Den Berg WB. Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis. Ann Rheum Dis. 2006;65(Suppl 3):iii29–iii33. doi:10.1136/ard.2006.05852917038468
   PubMedGoogle Scholar
• Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol. 2007;213(3):626–634. doi:10.1002/jcp.2125817786965
   PubMed Web of Science ®Google Scholar
• Mengshol JA, Vincenti MP, Brinckerhoff CE. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. Nucleic Acids Res. 2001;29(21):4361–4372. doi:10.1093/nar/29.21.436111691923
   PubMed Web of Science ®Google Scholar
• Billinghurst RC, Dahlberg L, Ionescu M, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest. 1997;99(7):1534–1545. doi:10.1172/JCI1193169119997
   PubMed Web of Science ®Google Scholar
• Kim YI, Park JE, Brand DD, Fitzpatrick EA, Yi AK. Protein kinase D1 is essential for the proinflammatory response induced by hypersensitivity pneumonitis-causing thermophilic actinomycetes Saccharopolyspora rectivirgula. J Immunol. 2010;184(6):3145–3156. doi:10.4049/jimmunol.090371820142359
   PubMedGoogle Scholar
• Park JE, Kim YI, Yi AK. Protein kinase D1: a new component in TLR9 signaling. J Immunol. 2008;181(3):2044–2055. doi:10.4049/jimmunol.181.3.204418641342
   PubMedGoogle Scholar
• Cobbaut M, Van Lint J. Function and regulation of protein kinase D in oxidative stress: a tale of isoforms. Oxid Med Cell Longev. 2018;2018:2138502. doi:10.1155/2018/213850229854077
   PubMedGoogle Scholar
• Baker J, Falconer AMD, Wilkinson DJ, Europe-Finner GN, Litherland GJ, Rowan AD. Protein kinase D3 modulates MMP1 and MMP13 expression in human chondrocytes. PLoS One. 2018;13(4):e0195864. doi:10.1371/journal.pone.019586429652915
   PubMedGoogle Scholar
• Chung R, Foster BK, Xian CJ. Inhibition of protein kinase-D promotes cartilage repair at injured growth plate in rats. Injury. 2013;44(7):914–922. doi:10.1016/j.injury.2013.01.03823427856
   PubMedGoogle Scholar
• Lee Y, Kim H, Kim S, Kim KH, Chung JH. Activation of toll-like receptors 2, 3 or 5 induces matrix metalloproteinase-1 and −9 expression with the involvement of MAPKs and NF-kappaB in human epidermal keratinocytes. Exp Dermatol. 2010;19(8):e44–e49. doi:10.1111/j.1600-0625.2009.00963.x19758322
   PubMedGoogle Scholar
• Liang KC, Lee CW, Lin WN, et al. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells. J Cell Physiol. 2007;211(3):759–770. doi:10.1002/jcp.2099217311279
   PubMedGoogle Scholar
• Park JE, Kim YI, Yi AK. Protein kinase D1 is essential for MyD88-dependent TLR signaling pathway. J Immunol. 2009;182(10):6316–6327. doi:10.4049/jimmunol.080423919414785
   PubMedGoogle Scholar
• Upadhyay K, Park JE, Yoon TW, et al. Group B streptococci induce proinflammatory responses via a protein kinase D1-dependent pathway. J Immunol. 2017;198(11):4448–4457. doi:10.4049/jimmunol.160108928461572
   PubMedGoogle Scholar
• Sophia Fox AJ, Bedi A, Rodeo SA. The basic science of articular cartilage: structure, composition, and function. Sports Health. 2009;1(6):461–468. doi:10.1177/194173810935043823015907
   PubMedGoogle Scholar
• Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Front Pharmacol. 2015;6:286. doi:10.3389/fphar.2015.0028626648870
   PubMed Web of Science ®Google Scholar
• Bhatti FUR, Hasty KA, Cho H. Anti-inflammatory role of TPCA-1 encapsulated nanosomes in porcine chondrocytes against TNF-alpha stimulation. Inflammopharmacology. 2019. doi:10.1007/s10787-018-0542-5
   Web of Science ®Google Scholar
• Cho H, Pinkhassik E, David V, Stuart JM, Hasty KA. Detection of early cartilage damage using targeted nanosomes in a post-traumatic osteoarthritis mouse model. Nanomedicine. 2015;11(4):939–946. doi:10.1016/j.nano.2015.01.01125680539
   PubMed Web of Science ®Google Scholar
• Cho H, Seth A, Warmbold J, Robertson JT, Hasty KA. Aging affects response to cyclic tensile stretch: paradigm for intervertebral disc degeneration. Eur Cell Mater. 2011;22:137–145; discussion 145–136.
   PubMed Web of Science ®Google Scholar
• Choi EK, Jang HC, Kim JH, et al. Enhancement of cytokine-mediated NF-kappaB activation by phosphatidylinositol 3-kinase inhibitors in monocytic cells. Int Immunopharmacol. 2006;6(6):908–915. doi:10.1016/j.intimp.2006.01.00716644476
   PubMedGoogle Scholar
• Sizemore N, Leung S, Stark GR. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol. 1999;19(7):4798–4805. doi:10.1128/mcb.19.7.479810373529
   PubMedGoogle Scholar
• Gold MR, Scheid MP, Santos L, et al. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase. J Immunol. 1999;163(4):1894–1905.10438924
   PubMed Web of Science ®Google Scholar
• Henrotin YE, Bruckner P, Pujol JP. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage. 2003;11(10):747–755.13129694
   PubMed Web of Science ®Google Scholar
• Marchev AS, Dimitrova PA, Burns AJ, Kostov RV, Dinkova-Kostova AT, Georgiev MI. Oxidative stress and chronic inflammation in osteoarthritis: can NRF2 counteract these partners in crime? Ann N Y Acad Sci. 2017;1401(1):114–135. doi:10.1111/nyas.1340728662306
   PubMed Web of Science ®Google Scholar
• Lepetsos P, Papavassiliou AG. ROS/oxidative stress signaling in osteoarthritis. Biochim Biophys Acta. 2016;1862(4):576–591. doi:10.1016/j.bbadis.2016.01.00326769361
   PubMed Web of Science ®Google Scholar
• Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011;21(1):103–115. doi:10.1038/cr.2010.17821187859
   PubMed Web of Science ®Google Scholar
• Rigoglou S, Papavassiliou AG. The NF-kappaB signalling pathway in osteoarthritis. Int J Biochem Cell Biol. 2013;45(11):2580–2584. doi:10.1016/j.biocel.2013.08.01824004831
   PubMed Web of Science ®Google Scholar
• Yasuhara R, Miyamoto Y, Akaike T, et al. Interleukin-1beta induces death in chondrocyte-like ATDC5 cells through mitochondrial dysfunction and energy depletion in a reactive nitrogen and oxygen species-dependent manner. Biochem J. 2005;389(Pt 2):315–323. doi:10.1042/BJ2004199615784009
   PubMedGoogle Scholar
• Wang L, Gai P, Xu R, et al. Shikonin protects chondrocytes from interleukin-1beta-induced apoptosis by regulating PI3K/Akt signaling pathway. Int J Clin Exp Pathol. 2015;8(1):298–308.25755716
   PubMed Web of Science ®Google Scholar
• Zhou PH, Liu SQ, Peng H. The effect of hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis. J Orthop Res. 2008;26(12):1643–1648. doi:10.1002/jor.2068318524010
   PubMed Web of Science ®Google Scholar
• Blanco FJ, Lotz M. IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res. 1995;218(1):319–325. doi:10.1006/excr.1995.11617537695
   PubMedGoogle Scholar
• Bhatti FUR, Kim SJ, Yi AK, Hasty KA, Cho H. Cytoprotective role of vitamin E in porcine adipose-tissue-derived mesenchymal stem cells against hydrogen-peroxide-induced oxidative stress. Cell Tissue Res. 2018;374(1):111–120. doi:10.1007/s00441-018-2857-329951700
   PubMedGoogle Scholar
• Rao Z, Wang S, Wang J. Peroxiredoxin 4 inhibits IL-1beta-induced chondrocyte apoptosis via PI3K/AKT signaling. Biomed Pharmacother. 2017;90:414–420. doi:10.1016/j.biopha.2017.03.07528391163
   PubMed Web of Science ®Google Scholar
• Sillat T, Barreto G, Clarijs P, et al. Toll-like receptors in human chondrocytes and osteoarthritic cartilage. Acta Orthop. 2013;84(6):585–592. doi:10.3109/17453674.2013.85466624237425
   PubMed Web of Science ®Google Scholar